IBIO vs RPRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

IBIO

36.7
AI Score
VS
RPRX Wins

RPRX

39.7
AI Score

Investment Advisor Scores

IBIO

37score
Recommendation
AVOID NEW MONEY

RPRX

40score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric IBIO RPRX Winner
Forward P/E 0 34.3643 Tie
PEG Ratio 0 2.1054 Tie
Revenue Growth -100.0% 13.3% RPRX
Earnings Growth 0.0% -50.8% IBIO
Tradestie Score 36.7/100 39.7/100 RPRX
Profit Margin 0.0% 25.7% RPRX
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED RPRX

Relative Price Performance (Last 90 Days)

IBIO 1M: -2.4% · 3M: -46.7% RPRX 1M: +16.9% · 3M: +17.7%

Current Technical Phase

IBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -20.3%), weak momentum, RSI 41

RSI (14): 41.3 · Price: $0.76

RPRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.7% over 20 days), RSI 71

RSI (14): 71.3 · Price: $68.97

Fundamentals Snapshot

Metric IBIO RPRX
Market Cap — —
Forward P/E -2.5 11.7
Trailing P/E — 45.8
Revenue (TTM) — —
Revenue Growth -1.0% 0.1%
Gross Margin 1.0% 1.0%
Operating Margin -301.4% 0.6%
EPS -0.27 1.53
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, RPRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.